LAZURITON NANO BIOTECHNOLOGY (USA): Discussion and analysis by management of the financial position and operating results. (form 10-Q)
Caution Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q, including this discussion and analysis by management, contains or incorporates forward-looking statements. All statements other than statements of historical fact made in the report are forward-looking. In particular, the statements contained in this document concerning the outlook for the industry and the future results of operations or financial condition are forward-looking statements. These forward-looking statements can be identified by the use of words such as “believes”, “believes”, “could”, “maybe”, “probably”, “plans”, “plans”, “expects” , “Could”, “will” or “should” or other variations or similar words. No assurance can be given that the future results anticipated by forward-looking statements will be achieved. Forward-looking statements reflect the current expectations of management and are inherently uncertain. results may differ significantly from management’s expectations.
The following discussion and analysis should be read in conjunction with our financial statements, included herein. This discussion should not be taken to imply that the results discussed here will necessarily continue into the future, or that any conclusions drawn here will necessarily be indicative of actual operating results in the future. Such a discussion represents only the best current assessment of our management.
We have indicated in our financial statements for the three months ended
We need additional funds to meet its ongoing obligations and to fund expected operating losses. Our auditor has expressed substantial doubts about our ability to continue to operate. Our ability to continue to operate depends on raising capital to fund its initial business plan and ultimately achieve profitable operations. These financial statements do not include any adjustment relating to the recoverability and classification of the amounts of recognized assets, nor to the amounts and classification of liabilities that could result from this uncertainty.
We expect to incur marketing, professional and administrative expenses as well as expenses associated with maintaining our records with
If we cannot raise additional funds, we will have to cease trading. As a result, our common stock investors would lose their entire investment.
Results of Operations
Three months ended
Net sales: We did not generate any sales for the three months ended
General and administrative expenses: General and administrative expenses consist mainly of fees for legal and professional services. General and administrative costs were
Net loss: Our net loss was
11 Table of Contents
Liquidity and capital resources
Cash and cash equivalents were
We had negative working capital of
Net cash from operating activities was
and 2020. The net losses for both periods were offset by changes in assets and liabilities.
We had no net cash flow from investing or financing activities during the three months ended
We had no net change in cash and cash equivalents for the three months ended
Critical Accounting Policies
The preparation of financial statements in accordance with generally accepted accounting principles in
Off-balance sheet provisions
We were not aware of any off-balance sheet arrangements at
Recent accounting positions
The Company has reviewed all accounting pronouncements recently issued but not yet effective, and does not believe that the future adoption of such pronouncements could have a material impact on its financial condition or results of operations.
Our opinion is that inflation has not had a material effect on our operations and should not have a material effect on our operations.
© Edgar online, source